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A  large number of studies have indicated  that the activation of T  helper cells for 
both antibody (1-6) and cytolytic T  lymphocyte (CTL) 1 (7-11) 2 responses is restricted 
by products of the I  region of the major histocompatibility complex  (MHC), while 
the activation of CTL themselves is restricted by products of the K/D regions of the 
MHC  (12-14).  However, it  is less clear how and when during their developmental 
pathway T ceils acquire their MHC-restricted self-recognition specificity. Studies with 
chimeras (12,  15,  16) and thymus-grafted nude mice (17,  18) have indicated that the 
MHC  phenotype of the  thymus dictates  the  particular  MHC  determinants  that  T 
cells recognize as self-recognition elements. In addition,  the MHC phenotype of the 
extra-thymic environment  has  been  implicated  in  the  process  that  determines  the 
restriction  specificities of T  cells  (11,  14,  17,  19,  20).  In  vivo manipulation  of the 
expression  of MHC  products  may yield  a  better  understanding  of how  the  host 
environment  (thymic or extra-thymic)  determines restriction  specificities of T  ceils. 
One  approach  to  achieving  such  manipulation  is  by  in  vivo  administration  of 
antibodies (Ab) to MHC products. A few reports describe the effect of in vivo anti-Ia 
Ab (5, 21-26)  but no data on actual expression of I region products in the recipients 
are so far available. A recent report described suppression of B lymphocyte develop- 
ment in mice injected from birth with monoclonal anti-I-A Ab (27), i.e., surface Ia  +, 
IgM  ÷, and IgD  ÷ B ceils did not develop in such mice. 
The purpose of the present study was to determine whether such chronic adminis- 
tration of anti-Ia Ab into mice during their first weeks of life might influence their T 
cell self-recognition repertoire. We show here that chronic injection of anti-I-A  k Ab, 
starting in  neonatal  H-2  k mice, abrogates their ability to generate alloreactive and 
trinitrophenyl  (TNP)-specific splenic CTL responses.  Different mechanisms for this 
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defect were  evaluated, and  the results support  the  idea that  T  cells from  anti-I-A- 
treated mice are unable to recognize self or allogeneic I-A determinants;  in contrast, 
CTL  from  these  mice  are  able  to  recognize  both  self and  allogeneic K/D  region 
determinants.  A  decrease in expression of thymic I-A antigens paralleled this func- 
tional  defect.  These  findings are interpreted  as suggesting that  during early T  cell 
differentiation, education of some if not all K/D-restricted T  cells occurs on different 
thymic elements than the education of I-restricted T  cells. 
Materials  and  Methods 
Mice.  Term pregnant C3H/HeN (H-2k), Fl(C57BL/6 X C3H)(H-2 b ×  H-2k), and C57BL/ 
6  (H-2  b)  mice  were  obtained  from  the  Small Animal  Section,  Research  Service, National 
Institutes of Health; all adult mice (BALB/c, C57BL/10, C3H/HeN, B10.BR)  were 8-12 wk 
old and obtained from The Jackson Laboratory, Bar Harbor, ME. B10--* B10.BR chimeras 
were made as described previously (4, 6) and used 8-12 wk after irradiation and bone marrow 
reconstitution. 
Antibodies and  Treatment of Mice.  Culture  supernatants containing monoclonal antibodies 
directed at  the  I-A  k determinant  Ia  17  (10-2.16,  IgG2b)  (28)  were  passed over protein A- 
Sepharose columns (Pharmacia Fine Chemicals, Piscataway, N  J) and the adsorbed antibodies 
were eluted with 2  M  potassium thiocyanate (Sigma Chemical Co., St.  Louis, MO).  These 
protein A-purified anti-I-A  k Ab were injected intraperitoneally into newborn mice according to 
a  previously described protocol (27).  Briefly, mice received three injections of 200/~g during 
their 1st wk of life, three injections of 400 ~g each during the 2nd wk and three injections of 600 
/zg each during the 3rd. Control mice were untreated littermates or mice receiving the same 
treatment with inappropriate monoclonal Ab, i.e., C3H(H-2 k)  mice treated with protein A- 
purified anti-LA  b (25-9-17,  IgG2a) (29)  and C57BL/6(H-2 b) mice treated with anti-I-A  k (10- 
2.16). 
Flow Microfluorometo~ (FMF).  FMF analysis of the anti-Ia-treated mice was performed as 
described (30)  using a  fluorescence-activated cell sorter (FACS II; B-D FACS Systems, Sun- 
nyvale, CA). Reagents used were monoclonal Ab (culture supernatants) to I-A  k (10-2.16)  (28), 
LA  b  (25-9.17)  (29),  H-2K  k  (11-4.1)  (31)  and  H-2D  k  (15-1-5)  (31),  in  combination  with 
fluorescein-conjugated, Fc fragment-specific, F(ab')2-goat anti-mouse IgG (FITC-F(ab')2-goat 
anti-mouse IgO-Fc) (Cappel Laboratories, Coehranville, PA). Preparation of cells and staining 
procedures were as described (30).  Briefly, 1 ×  106 thymus or spleen cells were incubated at 
4°C  for 45  min  with  anti-I-A or anti-H-2K/D  reagents;  they were then  washed  twice by 
centrifugation, incubated at 4°C  for 45  min with saturating amounts of FITC-F(ab')2-goat 
anti-mouse IgG-Fc, washed twice again, resuspended and analyzed for fluorescence. Lyt-marker 
analysis was performed with directly fluoresceinated nonallele-specific rat anti-mouse Lyt- 1 and 
Lyt-2 monoclonal Ab (Becton, Dickinson & Co., Sunnyvale, CA). All procedures were performed 
in  Hanks'  balanced salt  solution containing 0.1%  bovine serum  albumin  and  0.1%  NAN3. 
Briefly, data were collected on  5  ×  104  viable cells, as determined by forward light scatter 
intensity, and analyzed for minimum numbers of positive cells by integration of immunofluo- 
rescence (IF) profiles to determine the percentage of positive cells above a selected level of IF 
intensity  (30).  Data  are displayed as percentages of positive cells above the fluoreseeinated 
reagent background or (when direct staining is used) above unstained background values. 
Generation of CTL Responses.  4 ×  106 responder spleen cells or thymocytes were cultured with 
2-4 ×  106  1,500 rad irradiated splenic stimulator cells in 2 ml of Dulbecco's modified Eagle's 
medium, supplemented as described (16,  17). TNP modification was performed with 10 mM 
trinitrobenzene sulfonate according to Shearer et al. (13). After 5 d, specific lysis was determined 
in a 4-h 51Cr-release  assay, using concanavalin A (Con A)-induced splenic blasts as target cells. 
Specific 51Cr-release  --  [(experimental  -  spontaneous  release)/(maximum  -  spontaneous 
release)] ×  100. Data shown represent the means of triplicate determinations using 5  ×  103 
target cells (SD <  5%; maximum release range from  1,500 to 5,000  cpm; spontaneous release 
range from 6 to 19%) and are representative of at least four experiments. Lysis of unmodified 
target cells by TNP-specific CTL was <2% and therefore not indicated in the results. 
Preparation of Con A Supernatants.  In some experiments, Con A supernatants (Con A-SN) were 1934  T  CELL  REPERTOIRE  IN ANTI-I-A-TREATED  MICE 
used as an exogenous source of T  helper cell factors. Con A-SN were prepared from BALB/c 
mouse spleen cells as described (16)  and tested for the presence of IL-2 activity and the absence 
of mitogenic activity after addition of 0.2 M a-methyl-D-mannoside as described (16). The Con 
A-SN were used at a  10-25%  (vol/vol) concentration, whichever was optimal for the particular 
preparation. 
Test for Accessory Cell Depletion and Function.  Spleen cells were depleted of adherent cells by 
passage  over G-10  Sephadex  columns  as  previously  reported  (4),  with  the  modification  of 
incubating  the  spleen  cells on  the  columns  for  30  rain  at  37°C.  This  procedure  markedly 
reduces the percentage of latex-ingesting cells  (4)  and, when applied  to both  responder and 
stimulator cell populations, completely abrogates CTL responses to TNP self and alloantigens 
(32). The CTL response of such G-10 passed spleen cells can be restored by a radiation-resistant, 
non-T,  non-B,  glass-adherent,  Ia-positive,  latex-ingesting  cell population  (32,  33)  present  in 
normal spleen. 
Results 
In Vitro Effects of Monoclonal Anti-I-A k Ab on TNP-Specific CTL Responses.  The aim of 
the present  study was to investigate  the effect  of in  vivo anti-I-A treatment on CTL 
responses.  To  illustrate  that  there indeed  is a  role for I-A-recognizing T  cells in  the 
generation  of TNP-specific  CTL-responses,  the effect of monoclonal  anti-I-A k Ab on 
the in  vitro generation  of TNP-specific  CTL  responses was first studied.  In Fig.  1 A, 
it can  be seen that  CTL  responses  generated  in  vitro in  the presence of monoclonal 
10-2.16  (anti-I-A  k)  Ab  are  inhibited  in  a  specific  fashion,  i.e.,  H-2k-bearing  spleen 
cells are blocked but  H-2b-bearing  spleen cells are not. In addition,  this inhibition  is 
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Fro.  l.  In vitro inhibition ofTNP-specific CTL responses by anti-I-A  k is dependent on recognition 
of I-Ak-encoded determinants by helper T  cells.  (A)  Normal B10.BR  (H-2 k) or B10  (H-2  b) spleen 
cells were cultured with TNP-self stimulators and no (El) or 5 #g/ml (O)  anti-I-A  k antibody; (B) 
B10 ~  B 10.BR (H-2b ---* H-2  k) chimeric spleen cells were cultured with TNP-B 10.BR or TNP-B 10 
stimulator cells and no ([5]) or 5 #g/mt (O) anti-I-A  k antibody; (C) normal B1-0.BR  s~oleen ceils were 
cultured with Con A-SN in the absence  (El) or presence (©) of 5 ~g/ml anti-I-A  antibody and 
TNP-modified B 10.BR stimulator cells. KRUISBEEK ET  AL.  1935 
spleen cells from H-2k-restricted B 10--~ B 10.BR allogeneic chimeras are also inhibited 
by anti-I-A  k when stimulated by TNP-modified H-2  k stimulators (Fig.  1 B). Finally, 
Fig.  1 C also shows that the inhibitory effect of anti-I-A Ab is reversed when cultures 
are  supplemented  with  Con  A-SN,  supporting  the  notion  that  anti-Ia Ab  do  not 
directly interfere with  the  activation of CTL  but  rather with  the activation of Ia- 
specific T  helper cells required for the generation of CTL. A more extensive description 
of the  in  vitro  effects  of anti-I-A  k Ab  on  CTL-responses  will  be  given  elsewhere.  2 
Together  with  our  previous  studies  (14),  these  experiments  suggest  that  T  cells 
restricted to recognition of self-I-A determinants  are required  for the generation of 
TNP-specific CTL responses. 
Splenic CTL Responses Are Abrogated in Mice Treated  from Birth with Anti-I-A  Ab. In an 
attempt to evaluate the role of Ia antigens in the development of T  cell function, the 
expression of Ia antigens was suppressed by chronic administration of anti-Ia Ab to 
neonatal mice. Previous studies (27)  have shown that the number of surface Ia  + cells 
in the spleens of such mice is reduced >95%  as determined by FMF analysis. There 
was also a concomitant reduction of 80-95% in the number of surface IgM  + and IgD  + 
cells; the number of Thy-1 + cells was unaffected (27). 
In  the  present  report,  the  possibility was  tested  that  the  development  of T  cell 
function might also be affected by anti-Ia treatment. First, splenic CTL function was 
determined in anti-Ia-treated mice that had been shown by FMF analysis to exhibit 
the previously described suppression of splenic surface Ia  + cells (27). Fig. 2 shows that 
CTL responses to both TNP and alloantigens are significantly decreased in H-2 k mice 
treated  with  anti-I-A  k  Ab.  In  contrast,  H-2  b  mice  treated  with  anti-I-A  k  exhibit 
normal CTL responses, indicating that the antibody needs to react with I-A antigens 
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Fro. 2.  In anti-I-A-treated mice (C)) splenic CTL responses are abrogated in a haplotype-specific 
fashion. C3H/HeN  (H-2  k) or C57BL/6  (H-2  h) mice were treated from birth on with protein A 
purified anti-I-A  k (10-2.16) Ab, and their splenic CTL responses to either TNP-self or allogeneic 
BALB/c (I4-2  ~) stimulators were determined at 3 wk of age. Data are representative of 11 separate 
experiments. CTL responses to TNP-self were TNP-specific, in that no lysis of unmodified  target 
cells was observed (data not shown). Total spleen cell numbers and Thy-l  + cell numbers are equal 
in anti-Ia (©) and untreated mice (~) (27). 1936  T  CELL  REPERTOIRE  IN  ANTI-I-A-TREATED  MICE 
Iab  monoclonal  Ab  also  exhibit  normal  responses  (data  not  shown);  in  further 
experiments, control responses were generated with spleen cells from normal untreated 
littermates.  Thus,  anti-Ia-treatment  has  a  profound  effect  on  the  expression  of 
alloreactive and TNP-specific CTL function. The nature of the observed decrease was 
next investigated. 
Failure to Generate  CTL  in Anti-I-A-treated Mice Is Not Due to Demonstrable  Suppression, 
to  Carry-over  of  Blocking  Antibodies,  or  Solely  to  the  Absence  of  a  Functional  Accessory 
Cell.  Several mechanisms  may be  proposed  for the  abrogation  of CTL  function 
expression in  anti-I-A-treated mice.  First,  the  induction of a  suppressor cell might 
account for the observed decrease. Second, carry-over of anti-I-A Ab into the cultures 
might be responsible for the observed decrease. In either case, it might be anticipated 
that spleen cells from anti-I-A-treated mice, when mixed with spleen cells from normal 
mice, would suppress responses of the normal spleen cells.  The mixing experiment 
shown in Fig. 3 gives no indication for such a suppressive effect of spleen cells from 
anti-I-A-treated mice. A  mixture of equal numbers of normal and  anti-I-A-treated 
spleen cells generated alloreactive and TNP-self-reactive CTL responses comparable 
to those obtained with normal spleen cells alone (Fig. 3). Thus, although failure to 
demonstrate suppression does not provide conclusive evidence against it, these exper- 
iments make induction of suppressor cells or carry-over of anti-I-A Ab  a  less likely 
explanation for the observed abrogation of CTL responses in anti-I-A-treated mice. 
We next investigated whether a  lack of functional responder accessory cells might 
account  for the  observed defect. Anti-I-A  treatment  can  be expected to  not  only 
reduce Ia  ÷ B cells, but to also affect other Ia  + cells, such as accessory cells, required 
for the generation of CTL responses (32, 33).  Supplementation of spleen cells from 
anti-I-A-treated mice with a source of normal accessory cells should then reconstitute 
the defect. The results shown in Fig.  4  indicate that, even when  irradiated normal 
spleen cells are added to responder cells from anti-I-A-treated mice, the latter still are 
incapable of generating a normal CTL response to either allogeneic or TNP-modified 
stimulator cells. It might be noted that irradiated normal spleen cells are functionally 
competent accessory cells for reconstituting the CTL responses of spleen cells depleted 
of accessory cells by G10-passage (see Fig. 6). Thus, lack of a responder accessory cell 
in spleen cells from anti-I-A-treated mice is not sufficient to account for the observed 
defect. 
The Decreased Splenic  CTL  Responses of Anti-I-A-treated  Mice Is Not Due  to a  Defect in 
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FIo.  3.  The reduction in CTL responses from anti-I-A-treated mice is not mediated by suppression. 
Spleen cells from untreated H;2 k mice (4 ×  106/cuhure)  (---[3--) were mixed with equal numbers 
of either normal syngeneic spleen cells (- ~  -) or syngeneic spleen cells from anti-I-Ak-treated (4 
x  106/culture) mice ~D, and stimulated with TNP-modified H-2  k stimulator cells (left) or allogeneic 
H-2  d stimulator cells (right).  (O), anti-I-A-treated responders (4 ×  10n/culture). KRUISBEEK  ET  AL.  1937 
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Fxo. 4.  The decrease in CTL response from anti-I-A-treated mice is not due to the absence of a 
responder  aqcessory cell. Spleen cells from either  normal  (--[]--)  or  anti-I-Ak-treated 
(- --O- -) H-',I  k mice were supplemented with 2 ×  106 2,000 rad-irradiated normal spleen cells (-- 
[[]---, --4D---,  i espectively) that can provide accessory  cell function for accessory  cell-depleted  reduced 
CTL respons~  (see Fig. 6), and tested for their ability to generate TNP-self (left) or anti-H-2  d 
allogeneic C']'L responses (right). 
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Fto.  5.  The decrease of CTL responses from anti-I-A-treated mice can be restored by addition of 
Con A-SN. Spleen cells from either normal ([]D or anti-I-A  k (©) treated H-2  k mice were cultured in 
the presence (--) or absence (- - -) of Con A-SN and stimulated with TNP-modifled H-2  k (le~) or 
allogeneic H 2  d (tight) stimulator cells. 
CTL Compete~lce, But to a Defect  in LA-recognizing  T  Cell Function.  Generation of CTL 
responses is ( ependent on activation of both CTL precursor cells and T  helper cells 
(7-10, 28). Consequently, it was necessary to investigate whether the anti-I-A treat- 
ment affected CTL responses directly by reducing the CTL precursors or indirectly 
by affecting "C helper cell function, or both. CTL responses can be made independent 
of endogenot s T  helper cell activation by addition of a source of T  helper cell factors 
(34)  such as  those contained in Con A-SN. It can be seen in Fig. 5  that Con A-SN 
completely r;stored the anti-TNP and anti-allo-CTL responses of spleen cells from 
anti-I-A-trea  :ed mice. The response of normal spleen cells was also enhanced by Con 
A-SN (Fig. 5., but normal and anti-I-A-treated spleen cells reached the same elevated 
level of CTL responsiveness in the presence of Con A-SN. The target cell specificity 
of the response obtained in the presence of Con A-SN was the same as for cultures 
without Con A-SN (data not shown). Thus, these data suggest that the CTL precursors 
themselves a'e unaffected by treatment of mice with anti-I-A antibodies; rather it is 
likely that it ,s T  cells that normally are responsible for production ofT helper factors, 
such as prow ded by Con A-SN, that are defective in these mice. 
Defective'[" helper cell function could be due to either a lack of T  helper cells or to 
functional ittcompetence of the  T  helper  cells  that  are  present.  Results  from  an 
analysis of the Lyt-phenotype distribution of spleen cells from anti-I-A-treated mice 
support the latter possibility, as there is no significant difference between the number 
of Lyt-l+2  -  cells in spleen cells from normal and from  anti-I-A-treated mice: both 
contain ~6% Lyt-l+2  -  cells, as determined with monoclonal rat anti-mouse Lyt-1 and 1938  T  CELL REPERTOIRE IN ANTI-I-A-TREATED  MICE 
Lyt-2 typing reagents  (data not shown).  The relative number of Lyt-positive cells is 
very low  in  such  young mice  (<3  wk of age),  but  the  data  nonetheless  allow  the 
conclusion that cells with the Lyt phenotype of helper T  cells are present to the same 
extent in the spleens of anti-I-A-treated mice. Thus, it is more likely that the defect in 
T  helper cell function in anti-I-A-treated mice is not due to absence of T  helper cells, 
but  rather  a  consequence  of a  defect  in  the  ability  of T  helper  cells  to  attain 
competence. 
Effect of In  Vivo Anti-LA k  Treatment  on Splenic Accessory Cell Function.  A  defect in T 
helper cell function, as suggested above, could be due to either a direct effect of anti- 
I-A treatment on T  helper cell precursors, or reflect an effect on another cell type that 
is  necessary  for the  generation  of T  helper  cell  function.  A  direct  effect  on T  cells 
seems unlikely, as  10-2.16 antibodies  do not react with T  cells  (28). The most likely 
other cell type to be affected by anti-I-A treatment is the Ia-bearing accessory cell  (4, 
6, 33) involved in presenting antigens to T  helper cells. We have already excluded the 
possibility that  the defect in CTL responses of anti-I-A-treated mice is solely due to 
defective accessory cell  function  in  the responder cell  population,  but  these experi- 
ments  were  performed  under  conditions  in  which  the  stimulator  cells  contained 
normal accessory cells.  Thus, the possibility remained  that accessory cell function as 
well as T  helper cell function were affected by the in vivo anti-I-A treatment.  Indeed, 
if Ia-bearing accessory cells are involved in the education of T  cells recognizing self-Ia 
(35),  a  defect  in  accessory cell  function  might  conceivably be  the  reason  defective 
development  of the  Ia-specific T  cell  repertoire  occurs in  these  mice.  We  therefore 
evaluated  accessory cell  function  in  the  spleens  of anti-I-A-treated  mice by testing 
their  ability  to reconstitute  reduced  CTL  responses  from responder  and  stimulator 
spleen  cells  that  had  been depleted  of accessory cells by G10 passage  (32,  33).  The 
data shown in Fig. 6 indicate that G10 passage leads to an almost complete abrogation 
of splenic  TNP-specific  CTL  responses  that  can  be  reconstituted  by  addition  of 
irradiated  normal spleen  cells.  However, spleen  cells from anti-I-A-treated  mice did 
not reconstitute the reduced response of these G 10-passed cells. Previous data (32, 33) 
indicated that the reconstituting ability of spleen cells lies in a non-T, non-B, I-A/E  + 
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Fro. 6.  Spleen  cells from anti-I-Ak-treated H-2  k mice cannot function as accessory cells for CTL 
responses generated with macrophage-depleted spleen cells. Responder and stimulator spleen cells 
from normal  H-2  k mice  (]ZI) were G10-passed (--O---)  and their  defective TNP-reactive  CTL 
responses were reconstituted with irradiated spleen cells from either normal (---0--) or anti I-A  k- 
treated  (- -0- -) mice or with Con A-SN (- -O- -). Numbers in parentheses indicate numbers of 
spleen cells added. KRUISBEEK ET AL.  1939 
radiation-resistant,  phagocytic,  adherent  cell.  Thus,  the  present  data  demonstrate 
that  anti-I-A-treated mice lack functional  accessory cells, in addition  to lacking Ia- 
specific T  ceils. 
Effect  of In  Vivo Anti-I-A ~ Treatment on  Splenic CTL  Function in  (H-2 b  X  H-2k)F1 
Mice.  If T  helper cell function in anti-I-AU-treated mice is defective because devel- 
oping T  helper cells have not "learned" to recognize I-A  k, the question arises whether 
the I-A  k antigen expression is simply blocked by anti-I-A  k antibodies or whether those 
cells expressing I-A  k and responsible for "teaching" are absent from the environment. 
To address this question,  (H-2  b x  H-2k)Fa mice were treated with anti-I-A  k and their 
splenic CTL responses to H-2b-TNP, H-2k-TNP, and H-2d-allogeneic stimulator cells 
were determined. If the anti-I-A  k treatment had only blocked I-A  k antigen expression 
in vivo, it would be expected that in (H-2  b ×  H-2k)F1 mice, Iab-specific T  helper cells 
would be unaffected by treatment with anti-I-A  k antibodies. However, it can be seen 
in  Fig.  7 that both k-TNP, b-TNP and  allogeneic responses were all abrogated by 
anti-I-A  k treatment, suggesting that the anti-I-A  k treatment has actually removed or 
functionally  inactivated the cells that  educate both LA  b- and I-Ak-reactive T  cells. 
Nonetheless, this result could also be explained by steric hindrance if the distribution 
of I-A  b determinants on F1 cells is such that binding by antibody to I-A  k is sufficient 
to block recognition of LA  b, determinants. However, because in vitro blocking of I-A  k 
recognition sites on F1 cells leaves the other parental I-A determinants undisturbed 
(6),  2 it  is  more  likely  that  the  in  vivo  anti-I-A  k treatment  has  either  removed  or 
inactivated the F1 cells involved in educating T  cells to recognize both I-A  k and LA  b 
MHC determinants as self. 
The defects exhibited by in vivo anti-I-Ak-treated F~ mice are also in other ways 
comparable  to  those  observed  in  parental  H-2K  k  mice,  i.e.,  the  defective  CTL 
responses were restored by addition of Con A-SN (Fig. 7), and mixing equal numbers 
of untreated  and  anti-I-A-treated  spleen  cells  did  not  lead  to  suppression  of the 
response of normal spleen cells (data not shown). 
Effect of In Vivo Anti-I-A Treatment on I-A Antigen Expression in the Thymus.  The above 
data show that the defect in T  helper cell function in anti-I-A-treated mice coincides 
with a  defect  in  Ia-bearing accessory cell function.  It is  tempting to speculate that 
defective T  helper cell function is a secondary consequence of defective accessory cell 
function. If the absence of Ia-positive accessory cells has interfered with the develop- 
ment of Ia-restricted T  helper cell function, the thymus would be the most likely site 
for that  interference to have occurred,  as the  thymus is one of the sites where  the 
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EFFECTOR  TO TARGET  CELL RATIO 
FIG.  7.  Spleen  cells  from  (H-2  b  X  H-2k)Fx  mice  treated  with anti-I-A  k express decreased  TNP- 
specific and alloreactive CTL responses that can be reconstituted with Con A-SN. Spleen cells from 
either normal (1[]) or anti-I-Ak-treated  (O) (H-2  b X H-2k)F, mice were cultured with (--) or without 
(- -  -) Con A-SN and with either TNP-modified cells of each parental haplotype or allogeneic  (H- 
2  a) stimulator cells. 1940  T  CELL  REPERTOIRE  IN ANTI-I-A-TREATED MICE 
TABLE  I 
In  Vivo Anti-I-A k Treatment of Neonatal H-2 k Mice Leads  to a Decrease in Expression of I-A Antigens  in 
Both  the  Thymus  and the Spleen 
Cells 
Percent of cells positive with reagents 
specific for: 
I_Ak*  Kk/Dk¢ 
Thymocytes from control mice  § 
Thymocytes from anti-I-A-treated mice 
Spleen cells from control mice 
Spleen cells from anti-I-A-treated mice 
20.9"± 2.4  29.4 ±  2.0 
6.9 ::t: 2.3  24.2 ±  2.9 
23.9 +  2.6  66.1 ±  4.0 
3.1 ±  1.7  68.0 ±  4.3 
Data are expressed as means ±  SE of 11 separate experiments.  Values obtained with fluorescent  reagent 
only have already been subtracted. 
* Monoclonal anti-I-A  k antibody (clone  10-2.16). 
* Monoclonal anti-H-2K  k and anti-H-2D  k antibodies (mixture of clones  11-4-1 and  15-1-5). 
0 Control and anti-I-A-treated mice were 3 wk old. 
TABLE II 
In  (H-2 b X  H-2k)F1 Mice, In  Vivo Treatment "with Anti-I-A k of Neonates Leads to a Decrease in 
Expression  of Both LA  k and I-A  b in the Thymus and the Spleen 
Cells 
Perce ells positive with reagents 
specific for: 
I_Ak*  LAb* 
Thymocytes from control mice  § 
Thymocytes from anti-I-A-treated mice 
Spleen cells from control mice 
Spleen cells from anti-I-A-treated mice 
19.1±  1.9  18.8 ~  1.5 
6.8 ±  1.7  7.8 ±  1.5 
27.1 ±  3.4  23.3 ±  3.1 
2.6 ±  1.5  1.2 +  1.3 
Data are expressed as means ± SE of four separate experiments.  Values obtained with fluorescent  reagent 
only have already been subtracted. 
* Monoclonal anti-I-A  k antibody (clone 10-2.16). 
* Monoclonal anti-LA  b antibody (clone 25-9-17). 
§ Control and anti-I-A-treated mice were 3 wk old. 
MHC  specificity of T  cells is determined  (12,  15,  18).  It  was  therefore  of interest  to 
test  whether  the  anti-I-A treatment  resulted  in  changes  in  MHC-antigen  expression 
of thymocytes.  It  should  be noted  that  the Ia determinants  that  thymocytes  express 
are  predominantly  those  that  they  have  acquired  passively  from  Ia-positive  cells 
present  in  the thymus  microenvironment  (30).  Table  I  shows  that  thymocytes  from 
anti-I-Ak-treated  H-2  k  mice  exhibit  a  marked  decrease  in  I-A  k  antigen  expression, 
while  the  expression  of H-2K k  and  H-2D k antigens  is  not  significantly  affected.  To 
address  the possibility that  the decrease in number  of I-Ak-positive thymocytes might 
be  due  to  blocking  of Iak  determinants  on  thymocytes  by  the  in  vivo administered 
anti-Iak-antibodies,  thymocytes  and  spleen  cells  from  anti-I-Ak-treated  (H-2  b  ×  H- 
2k)F1  mice were also assayed  for their I-A antigen expression.  It can be seen in Table 
II  that  in  these  Fa  mice  both  I-A  k  and  I-A  b  antigen  expression  were  comparably 
reduced,  directly  demonstrating  that  the  in  vivo anti-I-A  k  treatment  has  removed, 
rather than blocked, Ia-bearing cells from the thymus and spleen of these mice. Thus, 
the absence of competent  Ia-specific T  cells in in vivo anti-Ia-treated  mice correlated 
with  the  absence  of Ia  ÷  cells  in  their  spleens  and  with  diminished  expression  of Ia 
antigens  in their thymi. KRUISBEEK  ET  AL.  1941 
TABLE  III 
Decrease in Splenic CTL Responses in Anti-I-A ~-Treated H-2 k Mice Coincides with Reduced I-A k 
Antigen Expression  m the  Thymus and Not with Suppressed Splenic I-A  k Antigen Expression 
Responder spleen cells from: 
Percent of I-Ak-positive 
cells in:* 
Percent specific 51Cr-release 
at effector target ratio 
of 20:1 ~ 
Thymus  Spleen  k-TNP  0  d a 
Experiment 1  ¶ 
Control mice  23,4  30.0  44.2  45.4 
Anti-I-Ak-treated mice  17,8  0.1  40.3  51.1 
Experiment 2** 
Control mice  24,0  24.4  49.7  51.6 
Anti-I-Aa-treated mice  6,3  1.5  6.2  10.0 
* Percent of cells staining with monoclonal anti-I-A  k (10-2.16); values obtained with fluorescent reagent 
only have already been subtracted. 
* Means of triplicate determinations. 
§ Stimulator and target cells: TNP-modified C3H spleen (H-2k). 
n Stimulator and target cells: BALB/c (H-2d). 
Individual experiment with hardly any thymic I-A  k reduction. 
** Individual experiment with usual thymic I-A  k reduction. 
To  determine  whether  the  absence  of competent  Ia-specific  T  cells  in  these 
experimental mice correlated with diminished  Ia expression in the thymus or with 
diminished Ia expression in the spleen, it would be necessary to assess T  cell function 
in anti-Ia-treated animals whose peripheral and  thymic Ia antigen expression were 
differentially suppressed. In the course of the present studies, one group of experimen- 
tal animals existed whose thymic I-A antigen expression was not markedly diminished, 
even though their peripheral I-A antigen expression was profoundly suppressed.  It 
can be seen in Table III, experiment 1, that in this group of experimental mice, T  cell 
function was  normal. Thus, the defective development of Ia-specific T  cells in this 
experimental system coincides with suppression of intrathymic I-A expression (as in 
Table III, experiment 2) and not with suppression of peripheral Ia expression. 
Discussion 
It is assumed that H-2-restricted T  cell specificities are the result of confrontation 
with the appropriate H-2 determinants during early T  cell differentiation (7-9,  11, 
12, 14-18, 35). However, little information is available concerning the mechanisms by 
which  precursor T  cells  are  affected by interaction with  H-2  determinants or the 
characteristics of the cell types presenting H-2 determinants to T  cells. In the present 
study, we approached these questions by attempting to modify the presentation of 
I-A determinants during early T  cell development. 
To this end, monoclonal Ab to I-A  k were injected into neonatal mice for a period 
of 3 wk. Previous studies indicated (27) that such treatment abrogates the development 
of surface Ia  ÷ B cells. We speculated that development of other, nonlymphoid Ia  ÷ cell 
types, such as those involved in T  cell education (7, 12, 35) might also be affected by 
anti-I-A treatment. It could be anticipated that such an alteration of the environment 
would  have  a  profound  effect on  the  specificity of the  developing  MHC-specific 
repertoire ofT cells. To test this possibility, allo- and TNP-self-specific CTL responses 
in  such  anti-I-A-treated  mice were  analyzed  at  the  end  of the  in  vivo treatment 1942  T  CELL REPERTOIRE IN ANTI-I-A-TREATED MICE 
period. It was observed that splenic CTL responses were almost completely abrogated 
by in vivo treatment with monoclonal anti-I-A  k Ab, and that such abrogation required 
Ia molecules expressed by the host which the Ab could recognize. Development of 
suppressor  cells,  carry-over of blocking  Ab,  lack  of responder  accessory  cells,  or 
defective CTL function were not responsible for the observed defect. The defect was 
due  to  the  absence  of competent  Ia-specific T  helper cells.  In  addition,  anti-I-A- 
treated mice exhibit reduced I-A antigen expression in the thymus and defective Ia- 
bearing  accessory  cell  function  in  the  spleen.  It  was  found  that  the  absence  of 
competent  Ia-specific  T  helper  cells  correlated  better  with  reduced  I-A  antigen 
expression  in  the  thymus  than  it  did  with  reduced  I-A  antigen  expression  in  the 
periphery. The most straightforward interpretation of these data is that, for develop- 
ment of Ia-specific helper T  cells to occur, precursor T  cells need to interact with Ia- 
antigens  in  the  thymus,  and  treatment  with  anti-Ia  Ab  has  interfered  with  this 
development. Finally, the mechanism of this interference by anti-I-A Ab was shown 
to be due to the actual removal or functional inactivation of those Ia-positive elements 
responsible for the education of I-A-recognizing T  cells. 
One implication of these findings is that education of at least most self K/D region- 
specific  T  cells  (i.e.,  TNP-specific  CTL  precursor  cells)  (11,  14)  occurs  through 
interaction with different elements than the education of self-I region-specific T  cells. 
Clearly, the anti-I-A treatment has not affected the repertoire of most K/D-recogniz- 
ing T  cells, as normal CTL responses were obtained when the need for T  helper cell 
activation was bypassed by culturing responder cells in the presence of Con A-SN. 
Since anti-I-A treatment  has removed I-A  + cells  (either identical to accessory cells 
(35)  or unique "teaching" cells)  that  are involved in T  helper cell education, then 
precursor CTL self-K/D-recognition specificities must  have arisen  at  least  in  part 
from interaction with other cell types. Our recent observation (11,  14) that self-K/D- 
recognizing T  cells differentiate both intra- and extrathymically, while self-I region- 
specific T  cells seem to differentiate exclusively intrathymically (14,  18) is consistent 
with this interpretation. 
The present  studies  also  showed that  anti-I-A  treatment  abrogated  alloantigen- 
specific CTL responses, and that Con A-SN could restore the defective response. The 
implication of this finding is that in the defective alloreactive CTL response the cause 
of the defect also lies at the helper T cell level, not at the precursor CTL level. It then 
needs to be explained how a defect in recognizing self-I-A antigens results in a defect 
in alloreactive T  helper cell activation. There are several ways in which this finding 
can be explained. First, allo-Ia-specific T  helper cells might in fact all be specific for 
self-I-A plus  conventional antigen,  so  that  they require intrathymic  Ia education, 
which has been disturbed in these mice. Reports that several self-I-A plus antigen- 
specific T  cell clones and hybridomas (36-38) were cross-reactive with allogeneic I-A 
determinants support this notion. Second, the generation of allo-K/D region-specific 
CTL  responses  might  require  presentation  of the  allogeneic  determinants  in  the 
context of self-Ia allogeneic determinants (39, 40), but self-Ia-restricted T  helper cells 
are incompetent in these mice. Third, those intrathymic elements which are absent in 
these mice might not only educate T cells to recognize self-I-A, but might, in addition, 
be responsible for the differentiation into functional competence of all T  helper cells, 
regardless of their MHC  specificity. For example, if all T  helper cells must  have a 
receptor for IL-1, it is conceivable that intrathymic Ia-positive elements function to KRUISBEEK ET AL.  1943 
induce the expression of IL-1 receptors on developing T  helper cells. Whatever the 
precise explanation for the failure of alloreactive T helper cells to develop in anti-I-A- 
treated mice, it is likely to result from the same mechanism that results in the failure 
of self-Ia-specific T  helper cells to develop functional competence in this model. 
The current studies have used treatment with a  monoclonal anti-I-A  k reagent in 
vivo to study the functional role of I-A antigen expression during the development of 
the T  cell repertoire. The anti-I-A treatment inhibited an I region-restricted T  helper 
cell function, while leaving K/D region-restricted CTL function intact.  Moreover, 
this  treatment  reduced  expression  of I  region  determinants  intrathymically while 
leaving expression of K/D region products in the thymus intact. Because the thymus 
is one of the sites where the specificity of the T  cell repertoire is being determined, 
these findings suggest that confrontation with I region-encoded products during their 
development is  essential  for T  cells to establish  their I  region-restricted repertoire. 
Moreover, expression of K/D region-encoded products must be on different elements 
than  that  of I  region  products,  as  CTL  precursors  were  unaffected  by  anti-I-A 
treatment.  Thus, development of most of the K/D region-specific T  cell repertoire 
must occur on Ia-negative education elements. 
Summary 
Monoclonal antibodies to I-A  k were injected into neonatal H-2  k mice for a period 
of 3 wk. The spleens of such mice are devoid of Ia-positive cells.  Allo- and trinitro- 
phenyl (TNP)-self-specific cytotoxic T  lymphocyte (CTL) responses in such anti-I-A- 
treated  mice were almost  completely abrogated  at  the end  of the  2-3  wk  in  vivo 
treatment period. Development of suppressor cells, carry-over of blocking antibodies, 
lack of responder accessory cells, or defective CTL function were not responsible for 
the observed defect. As concanavalin A supernatant could restore the defect, it is more 
likely that the defect is due to the absence of competent Ia-specific T  helper cells. In 
addition, anti-I-A-treated mice exhibit reduced I-A antigen expression in the thymus 
and defective Ia-bearing accessory cell function in the spleen. It is postulated that, for 
development of Ia-specific T  cells to occur, precursor T  cells need to interact with Ia- 
encoded products in the thymus, and anti-Ia treatment interferes with this process. 
Finally, the mechanism of this interference was shown to be due to actual removal or 
functional inactivation of those I-A-positive elements responsible for the education of 
I-A-recognizing T  cells,  since  in  (H-2b×  H-2k)F1  mice,  treatment  with  anti-I-A  k 
antibodies results in abrogation of CTL responses to TNP in association with both 
parental haplotypes, while in the thymus of these mice expression of both I-A  k and 
I-A  b was reduced. 
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